Arizona Health Sciences

Publications

Year of Publication Title Faculty Association
2010 Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice. John M. Streicher, PhD
2010 A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus. George Watts, Ph.D.
2010 Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. John M. Streicher, PhD
2010 MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. John M. Streicher, PhD
2010 A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. Tally Largent-Milnes, Ph.D., Patrick W Mantyh, Todd Vanderah, PhD
2009 Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. Jeffrey J. Lochhead, PhD
2009 Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma. George Watts, Ph.D.
2009 Novel bifunctional peptides as opioid agonists and NK-1 antagonists. Tally Largent-Milnes, Ph.D., Edita Navratilova, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2008 DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. George Watts, Ph.D.
2008 Agglomerative epigenetic aberrations are a common event in human breast cancer. George Watts, Ph.D.
2008 Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells. George Watts, Ph.D.
2008 Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Tally Largent-Milnes, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2008 A structure-activity relationship study and combinatorial synthetic approach of C-terminal modified bifunctional peptides that are delta/mu opioid receptor agonists and neurokinin 1 receptor antagonists. Tally Largent-Milnes, Ph.D., Edita Navratilova, Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2008 The role of COX-2 in heart pathology. John M. Streicher, PhD
2008 Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. Tally Largent-Milnes, Ph.D., Todd Vanderah, PhD
2008 Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. Tally Largent-Milnes, Ph.D., Todd Vanderah, PhD
2007 Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma. George Watts, Ph.D.
2007 Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. George Watts, Ph.D.
2006 Epigenetic inactivation of the HOXA gene cluster in breast cancer. George Watts, Ph.D.
2006 Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161. George Watts, Ph.D.
2006 AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. George Watts, Ph.D.
2005 Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Jeffrey J. Lochhead, PhD
2005 Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. Jeffrey J. Lochhead, PhD
2005 Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT). Jeffrey J. Lochhead, PhD
2005 Serotonin-related gene expression in female monkeys with individual sensitivity to stress. John M. Streicher, PhD

Pages